Biblio

Export 60 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Mental Status Schedule  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
E. M. Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., “Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
B
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., “Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S., “Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.
D. Bensamoun, Guignard, R., Furst, A. J., Derreumaux, A., Manera, V., Darcourt, J., Benoit, M., Robert, P. H., and David, R., “Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.”, J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.
F. Bermejo-Pareja, Contador, I., Trincado, R., Lora, D., Sánchez-Ferro, Á., Mitchell, A. J., Boycheva, E., Herrero, A., Hernández-Gallego, J., Llamas, S., Galende, A. Villarejo, and Benito-León, J., “Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort.”, J Alzheimers Dis, vol. 50, no. 3, pp. 719-31, 2016.
C
J. - P. Coutu, Goldblatt, A., H Rosas, D., and Salat, D. H., “White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 329-42, 2016.
D
G. D'Onofrio, Panza, F., Sancarlo, D., Paris, F. F., Cascavilla, L., Mangiacotti, A., Lauriola, M., Paroni, G. H., Seripa, D., and Greco, A., “Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.”, J Alzheimers Dis, vol. 51, no. 2, pp. 427-37, 2016.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S., “Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.”, J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
E
P. Eustache, Nemmi, F., Saint-Aubert, L., Pariente, J., and Péran, P., “Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1035-50, 2016.
F
G. Fernández, Manes, F., Politi, L. E., Orozco, D., Schumacher, M., Castro, L., Agamennoni, O., and Rotstein, N. P., “Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.”, J Alzheimers Dis, vol. 50, no. 3, pp. 827-38, 2016.
K. C. Fraser, Meltzer, J. A., and Rudzicz, F., “Linguistic Features Identify Alzheimer's Disease in Narrative Speech.”, J Alzheimers Dis, vol. 49, no. 2, pp. 407-22, 2016.
G
M. Gallucci, Spagnolo, P., Aricò, M., and Grossi, E., “Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.”, J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
A. J García-Casal, Goñi-Imizcoz, M., M Perea-Bartolomé, V., Soto-Pérez, F., Smith, S. Jane, Calvo-Simal, S., and Franco-Martín, M., “The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 3, pp. 937-951, 2017.
B. E. Gavett, John, S. E., Gurnani, A. S., Bussell, C. A., and Saurman, J. L., “The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, “Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., “Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders.”, J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
G. Grande, Cucumo, V., Cova, I., Ghiretti, R., Maggiore, L., Lacorte, E., Galimberti, D., Scarpini, E., Clerici, F., Pomati, S., Vanacore, N., and Mariani, C., “Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation.”, J Alzheimers Dis, vol. 51, no. 1, pp. 57-67, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., “Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.”, J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
H
S. Hatashita and Wakebe, D., “Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.”, J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
J. Haworth, Phillips, M., Newson, M., Rogers, P. J., Torrens-Burton, A., and Tales, A., “Measuring Information Processing Speed in Mild Cognitive Impairment: Clinical Versus Research Dichotomy.”, J Alzheimers Dis, vol. 51, no. 1, pp. 263-75, 2016.
A. Homma, Atarashi, H., Kubota, N., Nakai, K., and Takase, T., “Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.”, J Alzheimers Dis, vol. 52, no. 1, pp. 345-57, 2016.
J
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C., “An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”, Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
A. Johnen, Frommeyer, J., Modes, F., Wiendl, H., Duning, T., and Lohmann, H., “Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia Based on Apraxia Profiles.”, J Alzheimers Dis, vol. 49, no. 3, pp. 593-605, 2016.
K
N. Y. Kirson, J Andrews, S., Desai, U., King, S. B., Schonfeld, S., Birnbaum, H. G., Ball, D. E., and Kahle-Wrobleski, K., “Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 295-307, 2018.
A. Koppara, Wolfsgruber, S., Kleineidam, L., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H., Heuser, I., Peters, O., Reischies, F. M., Jahn, H., Luckhaus, C., Hüll, M., Gertz, H. - J., Schröder, J., Pantel, J., Rienhoff, O., Rüther, E., Henn, F., Wiltfang, J., Maier, W., Jessen, F., Kornhuber, J., and Wagner, M., “The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 547-60, 2016.

Pages